SynthesisProstate cancer and prostatic diseases2024

Health-related quality of life in patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitors: the role of combination treatment therapy.

Luca Afferi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.